Get the Stockscreener App
1.66
39.50%
0.47
After Hours:
1.51
-0.15
-9.04%
Medicinova Inc stock is traded at $1.66, with a volume of 47.24M.
It is up +39.50% in the last 24 hours and up +30.71% over the past month.
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.
See More
Previous Close:
$1.19
Open:
$1.36
24h Volume:
47.24M
Relative Volume:
63.27
Market Cap:
$81.42M
Revenue:
$134.60K
Net Income/Loss:
$-11.81M
P/E Ratio:
-6.8908
EPS:
-0.2409
Net Cash Flow:
$-10.05M
1W Performance:
+34.96%
1M Performance:
+30.71%
6M Performance:
+9.21%
1Y Performance:
-1.19%
1-Day Range:
$1.20
$1.96
1-Week Range:
$1.168
$1.96
52-Week Range:
$1.13
$2.55
Medicinova Inc Stock (MNOV) Company Profile
Name
Medicinova Inc
Sector
Industry
Phone
858-373-1500
Address
4275 EXECUTIVE SQUARE, LA JOLLA, CA
Compare MNOV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MNOV
Medicinova Inc
|
1.66 | 58.37M | 134.60K | -11.81M | -10.05M | -0.2409 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Medicinova Inc Stock (MNOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-10-21 | Initiated | Maxim Group | Buy |
| Mar-25-19 | Resumed | B. Riley FBR | Buy |
| Mar-28-18 | Initiated | B. Riley FBR, Inc. | Buy |
| Apr-18-17 | Initiated | Credit Suisse | Outperform |
| Jan-04-13 | Reiterated | Ladenburg Thalmann | Buy |
| May-24-12 | Downgrade | MLV & Co | Buy → Hold |
| Oct-18-11 | Reiterated | MLV Capital | Buy |
| Jun-22-11 | Initiated | Global Hunter Securities | Buy |
| May-12-10 | Initiated | Wedbush | Outperform |
| Nov-12-08 | Reiterated | Ladenburg Thalmann | Buy |
| May-15-08 | Initiated | Rodman & Renshaw | Mkt Outperform |
| Jul-09-07 | Initiated | Punk, Ziegel & Co | Buy |
View All
Medicinova Inc Stock (MNOV) Latest News
What dividend safety score for MediciNova Inc. stockTrend Reversal & Reliable Trade Execution Plans - newser.com
Market reaction to MediciNova Inc.’s recent newsJuly 2025 Gainers & Safe Entry Trade Signal Reports - newser.com
MediciNova Research Sparks New Hope for Atherosclerosis Therapy - StocksToTrade
MediciNova’s Breakthrough Strategy in Atherosclerosis Treatment - timothysykes.com
Applying big data sentiment scoring on MediciNova Inc.Earnings Risk Summary & Safe Entry Zone Tips - newser.com
Developing predictive dashboards with MediciNova Inc. dataGap Up & Low Risk High Win Rate Stock Picks - newser.com
MediciNova, Inc. (MNOV) Stock Price, News, Quote & History - Yahoo! Finance Canada
Will MediciNova Inc. stock benefit from infrastructure spendingJuly 2025 EndofMonth & Verified Technical Signals - newser.com
MediciNova Advances Atherosclerosis Research with Novel Therapeutic Strategy - StocksToTrade
MediciNova’s New Research Drives Strategic Focus on Cholesterol Metabolism - timothysykes.com
MediciNova compounds demonstrate novel therapeutic approach for Atherosclerosis - Yahoo Finance
MediciNova Stock Surge: Unveiling the Latest Development - timothysykes.com
MediciNova (MNOV) Analyst Ratings: Consistent 'Buy' Rating Maint - GuruFocus
D. Boral Capital Maintains MediciNova (MNOV) Buy Recommendation - Nasdaq
MediciNova Stock Rockets 85% After-Hours On Promising Heart Study — Traders Hope For ‘Big Green Candle’ - Stocktwits
Key resistance and support levels for MediciNova Inc.Portfolio Growth Summary & Intraday High Probability Setup Alerts - newser.com
Will MediciNova Inc. stock remain a Wall Street favoriteBull Run & Daily Risk Controlled Trade Plans - newser.com
Why Did MediciNova Stock (MNOV) Jump Over 87% In After-Hours Trading? - Benzinga
MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in ... - Enidnews.com
MediciNova, Inc. Publishes Research on MN-002's Potential in Atherosclerosis Treatment in Journal of Atherosclerosis and Thrombosis - Quiver Quantitative
MediciNova (NASDAQ: MNOV) publishes tipelukast data: MN-002 enhances cholesterol efflux - Stock Titan
RMN.BE interactive stock chart | Medicinova Inc. R stock - Yahoo! Finance Singapore
Why MediciNova Inc. stock could see breakout soonQuarterly Trade Summary & Expert Curated Trade Setups - fcp.pa.gov.br
MediciNova Inc Stock Analysis and ForecastInterest Rate Changes & Stay Ahead With Daily Market Discussions - earlytimes.in
Medicinova Inc Stock (MNOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):